Abstract:Introduction MicroRNAs (miRNAs) are a class of small non-coding RNAs (20 to 24 nucleotides) that post-transcriptionally modulate gene expression. A key oncomir in carcinogenesis is miR-21 , which is consistently up-regulated in a wide range of cancers. However, few functional studies are available for miR-21 , and few targets have been identified. In this study, we explored the role of miR-21 in human breast cancer cells and tissues, and searched for miR-21 targets. Methods We used in vitro and in vivo assays to explore the role of miR-21 in the malignant progression of human breast cancer, using miR-21 knockdown. Using LNA silencing combined to microarray technology and target prediction, we screened for potential targets of miR-21 and validated direct targets by using luciferase reporter assay and Western blot. Two candidate target genes (EIF4A2 and ANKRD46) were selected for analysis of correlation with clinicopathological characteristics and prognosis using immunohistochemistry on cancer tissue microrrays. Results Anti-miR-21 inhibited growth and migration of MCF-7 and MDA-MB-231 cells in vitro , and tumor growth in nude mice. Knockdown of miR-21 significantly increased the expression of ANKRD46 at both mRNA and protein levels. Luciferase assays using a reporter carrying a putative target site in the 3' untranslated region of ANKRD46 revealed that miR-21 directly targeted ANKRD46 . miR-21 and EIF4A2 protein were inversely expressed in breast cancers (r s = -0.283, P = 0.005, Spearman's correlation analysis). Conclusions Knockdown of miR-21 in MCF-7 and MDA-MB-231 cells inhibits in vitro and in vivo growth as well as in vitro migration. ANKRD46 is newly identified as a direct target of miR-21 in BC. These results suggest that inhibitory strategies against miR-21 using peptide nucleic acids (PNAs)-antimiR-21 may provide potential therapeutic applications in breast cancer treatment.

Mirna-107 Inhibits Proliferation And Migration By Targeting Cdk8 In Breast Cancer

The Effects of Mirnas-107 on Cell Proliferation, Senescence and Invasion of Pancreatic Cancer PANC-1 Cells

Mir-145 Suppresses Breast Cancer Cell Migration by Targeting FSCN-1 and Inhibiting Epithelial-Mesenchymal Transition.

Mirna-26b Inhibits Cellular Proliferation by Targeting Cdk8 in Breast Cancer

Mir-433 Inhibits Breast Cancer Cell Growth Via the MAPK Signaling Pathway by Targeting Rap1a

Mir-760 Inhibits Proliferation and Migration by Targeting CDK8 in Human Breast Cancer Cell Line MDA-MB-231

MicroRNA-107 Inhibits Proliferation of Prostate Cancer Cells by Targeting Cyclin E1.

Knockdown of Mir-21 in Human Breast Cancer Cell Lines Inhibits Proliferation, in Vitro Migration and in Vivo Tumor Growth

Tumor-promoting Properties of Mir-8084 in Breast Cancer Through Enhancing Proliferation, Suppressing Apoptosis and Inducing Epithelial–mesenchymal Transition

Mir-143-3p Targeting LIM Domain Kinase 1 Suppresses the Progression of Triple-Negative Breast Cancer Cells.

Mir-3646 Promotes Cell Proliferation, Migration, and Invasion Via Regulating G2/M Transition in Human Breast Cancer Cells.

[Mir-101 Inhibits the Proliferation and Migration of Breast Cancer Cells Via Downregulating the Expression of DNA Methyltransferase 3A].

Mir-107 Targets TRIAP1 to Regulate Oral Squamous Cell Carcinoma Proliferation and Migration.

MicroRNA-107 Inhibits Tumor Growth and Metastasis by Targeting the BDNF-mediated PI3K/AKT Pathway in Human Non-Small Lung Cancer

Mir-142-5p Inhibits Cell Invasion and Migration by Targeting DNMT1 in Breast Cancer

Mir-200c Inhibits Breast Cancer Proliferation by Targeting Kras

MicroRNA-34a Suppresses Breast Cancer Cell Proliferation and Invasion by Targeting Notch1

Mir-202 Acts As a Potential Tumor Suppressor in Breast Cancer

Mir-221/222 Promote Cancer Stem-Like Cell Properties and Tumor Growth of Breast Cancer Via Targeting PTEN and Sustained Akt/NF-κB/COX-2 Activation.

MiRNA-26b Inhibits Proliferation by Targeting PTGS2 in Breast Cancer

Microrna-188-5p Promotes Apoptosis And Inhibits Cell Proliferation Of Breast Cancer Cells Via The Mapk Signaling Pathway By Targeting Rap2c